The global cord blood banking services market size is expected to reach USD 41.36 billion by 2030, registering a CAGR of 7.4% during the forecast period, according to a new report by Grand View Research, Inc. Key drivers of the market include increasing application of stem cell therapies in disease treatment, and rising prevalence of life threatening genetic disorders.
Moreover, increasing spending capacity is fueling the demand for advanced healthcare facilities including disease prevention and treatment. As a result, parents are increasingly demanding CBB services to ensure safety of their child’s future. Furthermore, private players are practicing marketing activities which are creating awareness about the availability of the CBB services and their benefits.
In addition, governments worldwide are promoting public CBB to develop ethnically diverse cord blood repository which would increase the chances of finding suitable human leukocyte antigen (HLA) match for the patients. As a result, availability of the ethnically rich CB repository coupled with anticipated rise in the stem cell therapies and bone marrow transplants, is expected to spur the CBB services during the forecast period.
Request a free sample copy or view report summary: Cord Blood Banking Services Market Report
Private bank segment accounted for the largest revenue share in 2023. High cost of collection, processing, and storage along with the maximum awareness created by marketing activities practiced by the players resulted in large revenue share of private banks across the globe.
Rising government support and no storage and collection costs are the major factors anticipated to drive the public banking sector during the forecast period from 2024 to 2030 with significant CAGR.
North America dominated the global market in 2023. Dominance of North America is owing to government support and high rate of stem cell therapy in the U.S. and Canada.
Moreover, high awareness and insurance coverage of cord blood banking and stem cell therapies is further boosting the growth of the market in North America
Densely populated emerging countries of Asia Pacific are anticipated to show significant growth during the forecast period from 2024 to 2030.
Factors such as increasing investment by global players, government support and rising healthcare expenditure are anticipated to boost the cord blood banking services market in Asia Pacific
Global CBB services sector is highly fragmented with presence of many private and public players. Few global players operate in various geographies through subsidiaries. While local players are operating independently in respective geographies.
Grand View Research has segmented the global cord blood banking services market based on service, bank, component, application, end-use, and region:
Cord Blood Banking Services Service Outlook (Revenue, USD Billion, 2018 - 2030)
Collection & Transportation
Processing
Analysis
Storage
Cord Blood Banking Services Bank Outlook (Revenue, USD Billion, 2018 - 2030)
Private
Public
Hybrid
Cord Blood Banking Services Component Outlook (Revenue, USD Billion, 2018 - 2030)
Cord Blood
Cord Tissue
Cord Blood Banking Services Application Outlook (Revenue, USD Billion, 2018 - 2030)
Cancer
Genetic Disorders
Blood Disorders
Immune Deficiencies
Metabolic Disorders
Other Applications
Cord Blood Banking Services End-use Outlook (Revenue, USD Billion, 2018 - 2030)
Hospitals
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cord Blood Banking Services Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Cord Blood Banking Services Market
Global Cord Blood Corporation
CBR Systems Inc.
Cryo-Cell International
Cordlife Group Limited
AlphaCord LLC
CSG-BIO
California Cryobank Stem Cell Services LLC
Cord Blood Foundation (Smart Cells International)
Singapore Cord Blood Bank
FamiCord
"The quality of research they have done for us has been excellent..."